Lauren Biscaldi is the Managing Editor of Drug Topics.
Mental Health Awareness Month: Resources Roundup
Check out this list of resources to share with patients who are experiencing mental health conditions.
Researchers Announce Positive Efficacy Results for Long-Acting Subcutaneous Olanzapine Injection
The drug, TEV-749, demonstrated statistically significant and clinically meaningful efficacy results.
Asthma and Allergy Awareness Month: Resources Roundup
Check out this list of resources to share with patients who are managing an allergy or asthma diagnosis.
Q&A: Navigating the Exponential Growth of Specialty Drugs
The specialty drug market has exploded in the last few decades.
Asembia: Pharmacists Have a Role in Health Care System Sustainability
As medication experts, pharmacists can advocate to organizational decision makers around the benefits of biosimilars.
Q&A: Understanding Future Impacts of the IRA
Data from 2024 are being used as a way to predict what changes may be on the way for 2025.
FDA Approves Myhibbin for Prophylaxis of Organ Rejection in Adult, Pediatric Transplant Recipients
Mycophenolate mofetil oral suspension is the only FDA-approved ready-to-use liquid formulation.
Specialty Drug Distribution Sensitive to Regulatory Changes: Video
The market is sensitive to both upstream and downstream pressures that impact drug pricing.
Specialty Drug Market Continues Upward Growth Trend
The specialty drug market has exploded, and will continue to grow across sectors such as oncology and neurology.
Video: The Inflation Reduction Act in 2024 and Beyond
A lack of clarity around certain provisions of the Inflation Reduction Act has presented challenges to payers.
Q&A: Inside the Vanderbilt Specialty Pharmacy-AstraZeneca Collaboration
A siloed approach to care can worsen patient outcomes, but collaboration between one health system specialty pharmacy and a manufacturer led to better patient care.
Goal Alignment Improves Pharmacist-Manufacturer Collaborations, Care
Understanding the goals of each party is the first step to a successful collaboration.
Real World Data Show That Pharmacist-Manufacturer Collaboration Improves Patient Outcomes
Collaboration between health system specialty pharmacists and pharmaceutical manufacturers can benefit patients in the long run.
Siloed Systems Hinder Patient Care
Collaboration between health system specialty pharmacies and manufacturers can benefit patients in the long run.
Hurdles In Access: Costly Switch Studies Block Wider Biosimilar Use
Addressing requirements around FDA interchangeability designations can increase the adoption of biosimilar substitutions at the pharmacy level.
Expert: Biosimilar Legislation Making Moves in the Right Direction
A recent bill introduced to Congress is intended to prevent product hopping, a practice that extends exclusivity and hinders the adoption of biosimilar therapies.
Distributors Play a Role in Patient Access Programs
Distributors can help manufacturers create patient access programs that reduce costs, copays, and co-insurance.
Incentives Drive Provider, Patient Biosimilar Adoption
One notable incentive includes the launch of biosimilars at both low- and high wholesale acquisition costs.
Biosimilars Poised to Save Billions in Health Care Spending
Pharmacists can help financial decision makers understand the value of biosimilar therapies.
Expert: Education of Providers, Patients Key to Biosimilar Uptake
Savings associated with biosimilar uptake are projected to reach $181 billion through 2027.
Q&A: How Health System Specialty Pharmacies Improve Costs and Care
The role of health care specialty pharmacies has expanded.
Health System Specialty Pharmacists Elevate Care Across Clinical Spaces
The expertise of health system specialty pharmacists, combined with better adherence and better affordability, leads to better patient outcomes.
Health System Specialty Pharmacies' Role in Cost Reduction
From medication adherence to patient counseling, clinical pharmacists at health system specialty pharmacies can play a role in reducing health care costs.
The Stages of Shingles
The clinical manifestations of shingles can be divided into 3 phases.
American Heart Association Launches Initiative to Include Pharmacists in Atrial Fibrillation Care
Despite a wealth of knowledge, pharmacists are frequently not consulted as part of the decision-making team in atrial fibrillation management.
Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval
This approval is the second biosimilar approval for manufacturer Alvotech.
Rx Roundup: Quiz of the Week — April 12, 2024
Test your pharmacy news knowledge with our weekly quiz.
FDA: Fasenra Approved As Add-On Maintenance Therapy for Severe Pediatric Asthma
Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.
Pfizer Announces Positive Top-Line Data for Abrysvo Immunization in Adults Aged 18 to 59 Years
Abrysvo is currently approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older, and in infants through the immunization of pregnant individuals.
FDA Approves Antibiotic Ceftobiprole Medocaril for Injection for 3 Indications
The antibiotic was approved to treat Staphylococcus aureas bacteremia, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia.